-transparent.png){kind=logo}
With the purpose of obtaining more potent and less toxic camptothecin (CPT) analogs, we prepared many derivatives of CPT. Among them, 7-ethyl-CPT (SN 22) and 7-ethyl-10-hydroxy-CPT (SN 38) showed strong antitumor activity with less toxicity. They were, however, insoluble and when they were made soluble, their activity was markedly diminished, as a result of cleavage of the delta-lactone ring. We therefore attempted to make soluble derivatives without breaking the delta-lactone ring and obtained 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxy-CPT (CPT-11), which showed very strong antitumor activity by i.p., i.v. or p.o. administration against the ascites type of L1210 leukemia, P388 leukemia, sarcoma 180, Meth A fibrosarcoma, B16 melanoma, Ehrlich carcinoma and MH134 hepatoma and the solid type of sarcoma 180, Meth A fibrosarcoma, Lewis lung carcinoma, C3H/HeN mammary carcinoma, Ehrlich carcinoma and MH134 hepatoma. The antileukemic activity of CPT-11 against L1210 was much higher than that of adriamycin. The acute toxicity of CPT-11 was extremely low, particularly in the case of oral administration, the LD50 being 765.3 mg/kg, 22 times greater than that of CPT-Na.
K Nitta, and
T Yokokura, and
S Sawada, and
T Kunimoto, and
T Tanaka, and
N Uehara, and
H Baba, and
M Takeuchi, and
T Miyasaka, and
M Mutai
July 2005,
Bioorganic & medicinal chemistry letters,
K Nitta, and
T Yokokura, and
S Sawada, and
T Kunimoto, and
T Tanaka, and
N Uehara, and
H Baba, and
M Takeuchi, and
T Miyasaka, and
M Mutai
January 1996,
Journal de pharmacie de Belgique,
K Nitta, and
T Yokokura, and
S Sawada, and
T Kunimoto, and
T Tanaka, and
N Uehara, and
H Baba, and
M Takeuchi, and
T Miyasaka, and
M Mutai
August 2004,
Yao xue xue bao = Acta pharmaceutica Sinica,
K Nitta, and
T Yokokura, and
S Sawada, and
T Kunimoto, and
T Tanaka, and
N Uehara, and
H Baba, and
M Takeuchi, and
T Miyasaka, and
M Mutai
April 2005,
Bioorganic & medicinal chemistry letters,
K Nitta, and
T Yokokura, and
S Sawada, and
T Kunimoto, and
T Tanaka, and
N Uehara, and
H Baba, and
M Takeuchi, and
T Miyasaka, and
M Mutai
January 2019,
Journal of Asian natural products research,
K Nitta, and
T Yokokura, and
S Sawada, and
T Kunimoto, and
T Tanaka, and
N Uehara, and
H Baba, and
M Takeuchi, and
T Miyasaka, and
M Mutai
January 2019,
Bioorganic & medicinal chemistry letters,
K Nitta, and
T Yokokura, and
S Sawada, and
T Kunimoto, and
T Tanaka, and
N Uehara, and
H Baba, and
M Takeuchi, and
T Miyasaka, and
M Mutai
May 2020,
Molecules (Basel, Switzerland),
K Nitta, and
T Yokokura, and
S Sawada, and
T Kunimoto, and
T Tanaka, and
N Uehara, and
H Baba, and
M Takeuchi, and
T Miyasaka, and
M Mutai
October 1986,
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
K Nitta, and
T Yokokura, and
S Sawada, and
T Kunimoto, and
T Tanaka, and
N Uehara, and
H Baba, and
M Takeuchi, and
T Miyasaka, and
M Mutai
July 2004,
Bioorganic & medicinal chemistry,
K Nitta, and
T Yokokura, and
S Sawada, and
T Kunimoto, and
T Tanaka, and
N Uehara, and
H Baba, and
M Takeuchi, and
T Miyasaka, and
M Mutai
September 2003,
Yao xue xue bao = Acta pharmaceutica Sinica,
